As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...

Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion from a ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and ...

RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, ...

Confluent shares rally 11.4% Firm working with bankers after attracting interest from private equity and tech firms, sources say Interest fueled by corporate race for AI and firm's pressured valuation ...

Chris Chambers, MBA is the founder of The Einstein Bridge and The Turing Forge, as well as Principal of Chambers Capital Ventures, Inc. What we are witnessing at a macro level has huge implications, ...

Over 40% of fatal crash victims had THC levels far above legal limits, showing cannabis use before driving remains widespread. The rate didn’t drop after legalization, suggesting policy changes ...

According to Towards Healthcare experts, the global life sciences ERP software market is advancing rapidly, with projections indicating substantial revenue growth between 2025 and 2034. This expansion ...

A ransomware attack at Motility Software Solutions, a provider of dealer management software (DMS), has exposed the sensitive data of 766,000 customers. Motility (formerly known as Systems 2000/Sys2K) ...

NEW YORK – Personalized cancer firm Artera this week presented four studies on its multimodal artificial intelligence (MMAI) digital pathology-based risk stratification platform at the annual ...

Amid uncertainty surrounding federal research funding, Duke’s Clinical and Translational Science Institute (CTSI) secured a $69 million seven-year grant from the National Institutes of Health. The ...

SHENZHEN, China, Sept. 17, 2025 /PRNewswire/ -- MagicRNA, a clinical-stage biotechnology company pioneering in vivo CAR T-cell therapies, today announced the publication of the world's first clinical ...